These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27908273)

  • 1. Pharmacokinetic and Pharmacodynamic Features of Nanoemulsion Following Oral, Intravenous, Topical and Nasal Route.
    Choudhury H; Gorain B; Chatterjee B; Mandal UK; Sengupta P; Tekade RK
    Curr Pharm Des; 2017; 23(17):2504-2531. PubMed ID: 27908273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCS class IV drugs: Highly notorious candidates for formulation development.
    Ghadi R; Dand N
    J Control Release; 2017 Feb; 248():71-95. PubMed ID: 28088572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs.
    Kotta S; Khan AW; Pramod K; Ansari SH; Sharma RK; Ali J
    Expert Opin Drug Deliv; 2012 May; 9(5):585-98. PubMed ID: 22512597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Update on Nanoemulgel as Topical Drug Delivery System.
    Choudhury H; Gorain B; Pandey M; Chatterjee LA; Sengupta P; Das A; Molugulu N; Kesharwani P
    J Pharm Sci; 2017 Jul; 106(7):1736-1751. PubMed ID: 28412398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Trends in Self-Emulsifying Drug Delivery Systems (SEDDSs) to Enhance the Bioavailability of Poorly Water-Soluble Drugs.
    Karwal R; Garg T; Rath G; Markandeywar TS
    Crit Rev Ther Drug Carrier Syst; 2016; 33(1):1-39. PubMed ID: 27279337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and Future Prospects of Nanoemulsion as a Drug Delivery System.
    Yukuyama MN; Kato ET; Lobenberg R; Bou-Chacra NA
    Curr Pharm Des; 2017; 23(3):495-508. PubMed ID: 27799037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential and future scope of nanoemulgel formulation for topical delivery of lipophilic drugs.
    Sengupta P; Chatterjee B
    Int J Pharm; 2017 Jun; 526(1-2):353-365. PubMed ID: 28461261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-emulgel: Emerging as a Smarter Topical Lipidic Emulsion-based Nanocarrier for Skin Healthcare Applications.
    Anand K; Ray S; Rahman M; Shaharyar A; Bhowmik R; Bera R; Karmakar S
    Recent Pat Antiinfect Drug Discov; 2019; 14(1):16-35. PubMed ID: 31333141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral delivery of poorly soluble compounds by supersaturated systems.
    Lee TW; Boersen NA; Hui HW; Kurtulik P
    Ther Deliv; 2011 Jun; 2(6):685-90. PubMed ID: 22822502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-based drug delivery system enhances the oral absorption of lipophilic drugs with extensive presystemic metabolism.
    Zhang Z; Gao F; Jiang S; Ma L; Li Y
    Curr Drug Metab; 2012 Oct; 13(8):1110-8. PubMed ID: 22380010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview.
    Mignani S; El Kazzouli S; Bousmina M; Majoral JP
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1316-30. PubMed ID: 23415951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microemulsions: a novel approach to enhanced drug delivery.
    Talegaonkar S; Azeem A; Ahmad FJ; Khar RK; Pathan SA; Khan ZI
    Recent Pat Drug Deliv Formul; 2008; 2(3):238-57. PubMed ID: 19075911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the pulmonary delivery of poorly water-soluble drugs: influence of solubilization on pharmacokinetic properties.
    Tolman JA; Williams RO
    Drug Dev Ind Pharm; 2010 Jan; 36(1):1-30. PubMed ID: 19640248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery strategies for poorly water-soluble drugs: the industrial perspective.
    van Hoogevest P; Liu X; Fahr A
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1481-500. PubMed ID: 21895540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunities and challenges for the nasal administration of nanoemulsions.
    Comfort C; Garrastazu G; Pozzoli M; Sonvico F
    Curr Top Med Chem; 2015; 15(4):356-68. PubMed ID: 25579345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
    Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
    Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Submicron Emulsions and Their Applications in Oral Delivery.
    Mundada V; Patel M; Sawant K
    Crit Rev Ther Drug Carrier Syst; 2016; 33(3):265-308. PubMed ID: 27910752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: Formulation development, stability issues, basic considerations and applications.
    Rai VK; Mishra N; Yadav KS; Yadav NP
    J Control Release; 2018 Jan; 270():203-225. PubMed ID: 29199062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse approaches for the enhancement of oral drug bioavailability.
    Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE
    Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Drug Delivery Carrier Comprised of Nimodipine Drug Solution and a Nanoemulsion: Preparation, Characterization, in vitro, and in vivo Studies.
    Huang S; Huang Z; Fu Z; Shi Y; Dai Q; Tang S; Gu Y; Xu Y; Chen J; Wu X; Ren F
    Int J Nanomedicine; 2020; 15():1161-1172. PubMed ID: 32110014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.